Darifenacin
These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval:2004
e84f1ae3-b9a2-4a15-a299-c75373891cc1
HUMAN PRESCRIPTION DRUG LABEL
Jul 25, 2022
Torrent Pharmaceuticals Limited
DUNS: 916488547
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Darifenacin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Darifenacin
Product Details
FDA regulatory identification and product classification information